FDA accepts new drug application for UGN-103 in recurrent LG-IR-NMIBC

Urology Times · 2026-10-19 · Bullish AI sentiment

FDA accepts new drug application for UGN-103 in recurrent LG-IR-NMIBC Urology Times

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。